Group 1 - The meeting emphasized the importance of civil investment in stabilizing employment and the economy, proposing practical measures to stimulate civil investment vitality and development [4][5] - It was highlighted that civil investment should be expanded in new quality productivity, emerging service industries, and new infrastructure, with a focus on removing hidden barriers to investment [4][5] - The meeting discussed the need to enhance the overseas comprehensive service system to support enterprises in international cooperation and competition, including the establishment of overseas service stations in key countries [5] Group 2 - The meeting reviewed the situation of flood prevention and disaster relief, noting the challenges posed by extreme rainfall and the need for continuous vigilance in disaster management [3][4] - It was stated that there is a need to improve flood prevention capabilities in northern regions through enhanced infrastructure and emergency response measures [3][4] - The meeting also addressed the importance of promoting innovation in biomedical technology and ensuring the safety and quality of clinical research and applications [5]

Core Viewpoint - The State Council, led by Premier Li Qiang, has approved the draft regulations for the management of clinical research and clinical translation applications of biomedical new technologies, aiming to enhance innovation and development in China's biomedical technology sector [1] Group 1: Policy and Regulation - The meeting emphasizes the need to promote innovation and development in biomedical technology, accelerating research and the application of results [1] - It highlights the importance of ensuring safety and regulation in clinical research to safeguard the quality of clinical applications [1] Group 2: Industry Development - The focus is on upgrading the biopharmaceutical industry to create new competitive advantages [1] - The initiative aims to better enhance public health and well-being through effective innovation outcomes [1]